BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC
· Real-Time Price · USD
5.19
0.15 (2.87%)
At close: Oct 15, 2025, 3:59 PM
5.26
1.35%
After-hours: Oct 15, 2025, 04:24 PM EDT
2.87% (1D)
| Bid | 5.1 |
| Market Cap | 9.32M |
| Revenue (ttm) | 9.55M |
| Net Income (ttm) | -2.93M |
| EPS (ttm) | -1.64 |
| PE Ratio (ttm) | -3.16 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 5.26 |
| Volume | 26,835 |
| Avg. Volume (20D) | 1,146,050 |
| Open | 5.10 |
| Previous Close | 5.04 |
| Day's Range | 5.10 - 5.25 |
| 52-Week Range | 2.01 - 15.60 |
| Beta | 1.88 |
| Ex-Dividend Date | n/a |
About BGLC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BGLC
Website n/a
2 months ago
+60.99%
BioNexus Gene Lab shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+23.81%
Shares of companies within the broader industrial sector are trading higher, possibly amid overall market strength after President Trump delayed 50% EU tariffs to July.
